ARTICLE | Clinical News
GS7904L: Began Phase I trial
December 3, 2001 8:00 AM UTC
Gilead Sciences Inc. (GILD), Foster City, Calif. Product: GS7904L Business: Cancer Therapeutic category: Cell replication Target: Thymidylate synthase (TS) Description: Liposomal formulation of a TS...